11:23 EST Acadia Pharmaceuticals down 3% after Culper short report
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACAD:
- Acadia appoints names Jennifer Rhodes chief legal officer
- Acadia Pharmaceuticals initiated with an Outperform at Baird
- Needham upgraades Acadia Pharmaceuticals to Buy on positive survey data
- Acadia Pharmaceuticals upgraded to Buy from Hold at Needham
- Acadia Pharmaceuticals price target raised to $40 from $35 at Mizuho